financetom
Business
financetom
/
Business
/
BRIEF-Resideo To Acquire Snap One To Expand Presence In Smart Living Products And Distribution
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Resideo To Acquire Snap One To Expand Presence In Smart Living Products And Distribution
Apr 15, 2024 3:28 AM

April 15 (Reuters) - Resideo Technologies Inc ( REZI ):

* RESIDEO TO ACQUIRE SNAP ONE TO EXPAND PRESENCE IN SMART

LIVING

PRODUCTS AND DISTRIBUTION

* SNAP ONE HOLDINGS CORP ( SNPO ): PROPOSED DEAL FOR $10.75 PER SHARE

IN

CASH

* SNAP ONE HOLDINGS CORP ( SNPO ): PROPOSED DEAL FOR TRANSACTION

VALUE OF

APPROXIMATELY $1.4 BILLION

* SNAP ONE HOLDINGS CORP ( SNPO ): TRANSACTION HAS BEEN UNANIMOUSLY

APPROVED BY BOARDS OF DIRECTORS OF RESIDEO AND SNAP ONE

* SNAP ONE HOLDINGS CORP ( SNPO ): DEAL TRANSACTION VALUE INCLUSIVE

OF NET

DEBT

* SNAP ONE HOLDINGS CORP ( SNPO ): UPON CLOSING, SNAP ONE WILL

INTEGRATE

INTO RESIDEO'S ADI GLOBAL DISTRIBUTION BUSINESS

* SNAP ONE HOLDINGS CORP ( SNPO ): TRANSACTION IS EXPECTED TO BE

ACCRETIVE

TO RESIDEO NON-GAAP EPS IN FIRST FULL YEAR OF OWNERSHIP

* SNAP ONE HOLDINGS CORP ( SNPO ): TRANSACTION WITH FAVORABLE

REVENUE

GROWTH AND MARGIN PROFILE TO ADI AND RESIDEO AS A WHOLE

* SNAP ONE HOLDINGS ( SNPO ): RESIDEO TO USE PROCEEDS FROM COMMITTED

DEBT

FINANCING, CASH ON HAND TO FUND TRANSACTION

* SNAP ONE HOLDINGS ( SNPO ): RESIDEO TO ALSO USE PROCEEDS FROM $500

MILLION PERPETUAL CONVERTIBLE PREFERRED EQUITY INVESTMENT FROM

CD&R TO FUND TRANSACTION

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
Nov 10, 2025
AstraZeneca Plc ( AZN ) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory systolic blood pressure (SBP), as well as safety and tolerability in participants with resistant hypertension. • AZN is approaching key resistance levels. Find out why here. The company released topline data in October....
Mexico's Esentia expects to raise $610 million in IPO
Mexico's Esentia expects to raise $610 million in IPO
Nov 10, 2025
Nov 10 (Reuters) - Mexico's Esentia Energy Development aims to raise $610 million through an initial public offering, the firm said in a statement on Monday. ...
Northborne Partners Advises Disdero Lumber Company on its Sale to BlueLinx Holdings
Northborne Partners Advises Disdero Lumber Company on its Sale to BlueLinx Holdings
Nov 10, 2025
MINNEAPOLIS, Nov. 10, 2025 /PRNewswire/ -- Northborne Partners is pleased to announce that it served as financial advisor to Tumac Lumber Company (Tumac) in connection with the sale of its subsidiary, Disdero Lumber Company (Disdero), to BlueLinx Holdings ( BXC ) . Founded in 1953 and headquartered in Clackamas, Oregon, Disdero is a leading value-added wholesale distributor of a broad...
Brazilian oil firm Petrobras' workers approve potential strike
Brazilian oil firm Petrobras' workers approve potential strike
Nov 10, 2025
RIO DE JANEIRO, Nov 10 (Reuters) - Organized workers from Brazilian state-run oil firm Petrobras rejected a work agreement offered by the company and its subsidiaries, which prompted the approval of a state of strike, the workers' union said in a statement on Monday. According to the union, the motion approved allows the workers to go on strike at any...
Copyright 2023-2026 - www.financetom.com All Rights Reserved